16Apr 2024
Study Uncovers Link Between Anti-Thyroid Antibodies and Recurrent Miscarriage Risk

Study Uncovers Link Between Anti-Thyroid Antibodies and Recurrent Miscarriage Risk

A recent meta-analysis investigated the association between anti-thyroid antibodies and recurrent miscarriage (RM). The analysis included 28 studies involving 8,875 participants. Results indicated a significant link between anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies and RM prevalence (OR/RR = 2.02; 95% CI: 1.63–2.51). Specifically, anti-TPO (OR/RR = 1.59; 95% CI: 1.25–2.03) and anti-TG (OR/RR = 2.25; 95% CI: 1.56–3.23) antibodies were independently associated with RM. The findings suggest that women with these antibodies face a higher RM risk, warranting further investigation into their role and potential treatments. Limitations include variations in detection methods across studies, potential broader immune system disorders, and a lack of data on thyroxine therapy's impact on RM.

  • #gynaecology - ivf

Like

Save

Share